Skip to main content
Archives of Iranian Medicine logoLink to Archives of Iranian Medicine
. 2023 Aug 1;26(8):413–418. doi: 10.34172/aim.2023.63

Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis

Fereshteh Ghadiri 1, Mohammad Ali Sahraian 1, Fereshteh Ashtari 2, Seyed Mohammad Baghbanian 3, Nastaran Majdi-Nasab 4, Hamidreza Hatamian 5, Fardin Faraji 6, Asghar Bayati 7, Ehsan Sharifipour 8, Nazanin Jalali 9, Hossein Mozhdehipanah 10, Hoda Kamali 11, Saeideh Ayoubi 1, Sharareh Eskandarieh 1,*, Abdorreza Naser Moghadasi 1,*
PMCID: PMC10685736  PMID: 38301102

Abstract

Background:

Multiple sclerosis (MS) may be affected by socioeconomic status (SES). This study aims to explore the determinants of SES among Iranian patients with MS and examine how these factors relate to disability and disease progression.

Methods:

All patients with MS listed in the nationwide MS registry of Iran (NMSRI) until January 8, 2022, were included in this population-based study.

Results:

Among the 5153 patients, most were female (74.5%), married (70.8%), and did not hold an academic degree (53.8%). Unemployment (OR: 3.75) and being unmarried (OR: 2.60) were significantly associated with Expanded Disability Status Scale (EDSS)≥6, and the time to progression was shorter in the unemployed group (P value: 0.03). There was also a significant negative correlation between the time to progression and the age at disease onset.

Conclusion:

The study suggests that providing financial and social support to MS patients and their families through investment could reduce both individual and societal burdens.

Keywords: Iran, Multiple sclerosis, Socioeconomic status

Introduction

Multiple sclerosis (MS) is a potentially disabling disease affecting different aspects of patients’ life. Its prevalence has been rising in recent years.1 In terms of productivity changes, 60 hours could be lost over three months due to MS.2 Aside from the probable physical disabilities, the cognitive aspects could also pose a substantial burden to the patients, their close ones, and the society.3

Current evidence suggests a multifactorial model predisposing an individual to MS. Some studies mention culprit genes like HLA-DR15,4 besides 110 single nucleotide polymorphisms outside HLA regions,5 and female predominance,6 while many others highlight the role of environmental factors like Epstein-Barr virus, other viruses like cytomegalovirus and HHV-6, vitamin D, smoking, obesity, or the gene-environment interaction.7-10

Socioeconomic status (SES) is a widely discussed matter in the field of MS. Although the exact definition of “socioeconomic status” is not well established, educational level, employment, income, and insurance coverage are its main components.11 It is considered to affect the incidence and progression of the disease,12-14 and access to treatment15; it is also an aspect of patients’ lives that could be altered due to the disease. However, these associations are not quite straightforward. There are doubts about the exact mechanism and final determinants. Uncertain evidence suggests high SES level as a risk factor for developing MS.16 On the other hand, lower SES could be associated with a poorer outcome of the disease.17 One study by Mohtasham et al showed that the effect of some SES determinants like income and the education level of the fathers could be related to primary progressive MS (PPMS).18

Iran is a lower-middle-income country as the World Bank reports.19 There is evidence of rising MS prevalence and incidence in Iran.20,21 The cost of MS was estimated to be $238 124 160 in 2019-2020,22 or about US$ 34000 per patient23 which seems a notable number for Iran’s level of income. This high economic burden, in addition to international sanctions, could limit the patients’ access to treatments.24 To obtain a better understanding of the patients’ status, we investigated the SES determinants of Iranian MS patients. We also studied their relation to disability and disease progression. The results are hoped to shed light on the current condition which could be helpful in future policymaking.

Materials and Methods

This population-based study was conducted on all MS patients in the nationwide MS registry of Iran (NMSRI) up to January 8, 2022. This validated system has empowered subsequent policymakers to achieve a superior image of different aspects of disease conditions at a national level through qualified research.25-27 MS was diagnosed by neurologists based on McDonald’s criteria 2017.28 Registrars registered the data of subjects in 15 cities/ provinces, 12 MS societies, 3 referral hospitals, and 6 private clinics. Included were developed provinces, medium-developed provinces, and undeveloped provinces. The level of development was measured by 25 economic indices and ranked by factor analysis method.29,30

Data on basic characteristics (age, gender, marital status), socioeconomic determinants (family size, education level, employment, owning a home, health insurance), and disease-related variables (MS type (relapsing versus progressive), disease-modifying treatment, Expanded Disability Status Scale (EDSS) (higher or lower than 6), age at the onset of the disease, diagnosis delay since the first symptom, time from the onset of the disease to progression, using assistance equipment (cane, walker, wheelchair), participating in physical rehabilitation programs (physiotherapy, occupational therapy)) were obtained. In Iran, a person who is not employed and is not willing to be employed or is not interested in working in any economic activity is classified as “unemployed”. Typically, homemakers are classified under this category. Therefore, housewife females were entered as unemployed. There is mandatory governmental health insurance for every Iranian individual besides other insurance options with more extensive coverage. Descriptive analysis and logistic regression were performed in IBM® SPSS® version 26. To test normal distribution of quantitative variables, Kolmogorov-Smirnov normality test was adopted. For variables without a normal distribution, Mann-Whitney U test and Spearman rank test were applied as applicable. To build the final regression model, after finding possible statistically significant associations, known risk factors were fixed in the model and a stepwise forward method was used. For first-step univariate regression, P value < 0.2; and for the final model, P value < 0.05 were considered significant. To assure fulfilling logistic regression assumptions, Box-Tidwell test was used.

After informing the patients about the goals and structure of the study, they were free to enroll. Different access levels were used to reassure privacy and data security.

Results

After excluding incomplete files, data on a total of 5153 MS patients were evaluated. Their characteristics are summarized in Table 1. The majority of cases were female (74.5%), unemployed (65.1%), married (70.8%), and without an academic degree (53.8%).

Table 1. Basic Characteristics of the Participants .

Variable Number (%)*
Gender (female) 3837 (74.5)
Mean age (SD) 36.3 (9.8)
Employment status
Employed 1621 (31.5)
Unemployed 3357 (65.1)
Missing 175 (3.4)
Married 3647 (70.8)
Median family size (IQR) 4 (3-4)
Education
Illiterate 0 (0)
Without academic degree 2770 (53.8)
With academic degree 2300 (44.6)
Missing 83 (1.6)
Housing
Owning a home 3594 (69.7)
Rental accommodation 1444 (28.0)
Missing 115 (2.2)
No health insurance coverage 79 (1.5)
MS type
Relapsing 4247 (82.4)
Progressive 830 (16.1)
Missing 76 (1.5)
Mean onset age (SD) 29.3 (8.9)
Median diagnosis delay (IQR), year  ≥ 0 (0-1)
Median time to progression (IQR), year 8 (4-12)
Family history of MS
Positive 926 (18.0)
Negative 4079 (79.2)
Missing 148 (2.9)
EDSS ≥ 6 239 (4.6)
Using assistance equipment 371 (7.2)
Positive history of physical rehabilitation 677 (13.1)

SD, standard deviation; IQR, interquartile range.

*For quantitative variables, mean (SD) or median (IQR) are shown.

Most female patients (n: 2851/3837, 74.3%) were housewives. Among men, 427 (32.4%) were unemployed. Also, 211 patients (4%) were divorced at the time of the study. The mean age of unemployed men (39 ± 12.6) was significantly higher than those with a job (35.8 ± 9.1) (P value < 0.001). Out of 88 patients who declared a reason for their divorce, 25 (28%) stated MS as the reason. Having an academic degree was significantly associated with being employed (OR: 3.51, P value < 0.001).

Family history of MS was not significantly associated with any of the demographic, socioeconomic, and disease characteristics.

Considering EDSS ≥ 6 as the outcome measure, gender and age were fixed in the multivariable model. Of all socioeconomic determinants, unemployment and not being married were significantly associated with EDSS ≥ 6 (Table 2).

Table 2. The Output of Final Multivariable Regression Model .

Variable Exp (B) (95% CI) P value
Male gender 2.80 (2.04 – 3.84)  < 0.001
Age (y) 1.11  < 0.001
Not married 2.63 (1.90 – 3.64)  < 0.001
Unemployment 6.15 (3.82 – 9.90)  < 0.001

B, beta coefficient; CI, confidence interval; Exp (B), exponential B that equals to odds ratio (OR) for qualitative. variables.

Time from the onset of the disease to progression was not normally distributed (P value < 0.001). It was found that time to progression was significantly less in the unemployed group (P value: 0.03). Besides, a significant negative correlation was found between time to progression and age at disease onset (rho: - 0.22, P value < 0.001).

Discussion

This study depicts a clear view of the SES of Iranian MS patients.

The unemployment rate of 65% in general and 32.4% in men seems notable, compared to the reported unemployment rate of 9.4% in Iran in 2020.31 The higher mean age of unemployed men (39.3) (compared to 35.8 in men with a job) is another point to consider. Although the difference is not large, it may point to more job losses as time passes. Added to the facts that most Iranian MS cases are in this age range,32 many unemployed cases have families of around four, around 54% of the patients do not have an academic degree, and 28% do not own a house, this calls for the attention to the issues of employment and income in this group. This would aid patients in leading an independent life. Besides, solving these problems could reduce the considerable burden of the disease on the society.

Only a minority (n = 79, 1.5%), did not have any health insurance coverage. As MS treatment and follow-up could be quite expensive in Iran without insurance, the reasons for no coverage in even this small group should be investigated and solved.

Progression is an important subject in MS, imposing a considerable socioeconomic burden on the patient33 and the society.34 It is important to delay it, or once started, reduce its speed in order to limit the resulting disabilities. Around 16% of Iranian patients were in the progressive phase. Other studies estimate the frequency of progressive MS at 11% in Kermanshah (western Iran),35 and 14% in East Azerbaijan (northeastern Iran).36 The prevalence of progressive cases is around 14% in Denmark37 and Chile,38 around 27% in Germany,39 and 8% in Argentina.40 The difference in the statistics could be the result of the study population and variable definitions. For example, in the German study, only + 18-year-old cases were included, or in the survey from Argentina, secondary-progressive MS (SPMS), relapsing-remitting MS (RRMS), and clinically isolated syndrome (CIS) cases were considered relapsing-onset versus PPMS cases as progressive-onset MS.

The observed correlation of the mean onset-age with time to progression is in line with the results of a Swiss study by von Wyl et al,41 along with older studies.42,43 The higher inflammatory (and less degenerative) nature of the earlier-onset MS is the proposed underlying mechanism.

About 18% of participants had a family history of MS, which is in line with the results of another study from Iran (19%). However, as predicted for genetic predisposition, regional variances have been found.44 We could not find any association between the familial history of MS and the basic characteristics of the patients. However, in a study by Salehi et al, female gender and the RRMS/SPMS phenotypes were more frequent among familial cases but no such association was found regarding EDSS.44 A systematic review in 2021 estimated the prevalence of familial MS at around 11%. No association of gender with familial form was found.45

EDSS ≥ 6, indicating significant disability, was significantly higher in males and older patients as predicted.46 Its relation to unemployment and not being married is complicated. Both could be considered as possible predisposing factors and also consequent effects of the disease. A French study used European Deprivation Index and showed higher risk of reaching EDSS > 6 in more socioeconomically deprived patients.47 In the study by Harding et al, neighborhood-level average income was used as a measure of SES. They showed the higher SES levels could delay disability progression.12 From another point of view, job loss could be due to MS-related disabilities which highlights the need for work adaptations.48 In our study, unemployed cases progressed sooner than the others. Ware et al, using both neighborhood-level and participant-level indicators (education level), presented evidence that socioeconomic disparity is associated with an enhanced neurodegeneration process.49

With regard to marriage, cultural factors in Iran complicate final decisions based on current findings. Some partnered people may not declare their relationship status. In addition, the reasons for divorce or being single could not be exactly elucidated. Besides, the cultures differ in urban and rural areas and different cities. But generally, it is important to bear in mind that spousal support is crucial for rehabilitation.49

Regarding rehabilitation, around 140 patients with EDSS < 6 use assistance equipment. This could indicate that some cases have to use this equipment in some especial occasions. If proven, this should be taken into consideration in policy making for supporting these patients.

There is much recent insistence on motor rehabilitation in MS as a therapeutic option that could even change MRI markers.50 However, only 13% of our patients used such programs. As there is no precise data on the details of patients’ symptoms in our database, one could comment that not many of the patients might have motor weakness and so benefited from physical therapy or occupational treatment. Another explanation is the relative young age of the patients. One could speculate that as the mean age of the patients rises,51 there will be greater need for rehabilitation. Another point regarding MS care and services in Iran is that more than half of the subjects (51.9%) mentioned experiencing high stress level for increased costs of rehabilitation services24 while people with MS need long-term rehabilitation care.52

Iran is a country with a heterogeneous socioeconomic structure. In-country (rural to urban areas, small to big cities) immigration, access to medical facilities,53 and significant regional inequality54 complicate socioeconomic investigations in the country. Besides, this study relies on patients’ reports on variables like employment, housing, marriage history, family history, and using rehabilitation that could be biased. Our study design also bears the common limitations of a database method which may not be the best way to investigate a correlation. It should be emphasized that no final judgement could be made on the causative relationship between presumed determinants and outcome measures in the absence of more robust evidence. In other words, MS could affect and also be affected by socioeconomic performance of the patients. However, in the absence of stronger evidence, this could be the first step. Only including patient-related indicators could be considered another limitation. It is encouraged that neighborhood indicators are investigated in future reports.

In conclusion, the evidence shows that SES is an important factor in MS disease course. Investments in supporting MS patients and their families, financially and socially, could enhance this group’s physical and mental health, reducing the rate of progression, and decreasing the final burden of the disease on the individuals and the society.

Cite this article as: Ghadiri F, Sahraian MA, Ashtari F, Baghbanian SM, Majdi-Nasab N, Hatamian H. Economic and social standing of individuals in iran diagnosed with multiple sclerosis. Arch Iran Med. 2023;26(8):413-418. doi: 10.34172/aim.2023.63

Footnotes

Competing Interests

The authors declare that they have no conflict of interest.

Ethical Approval

As mentioned in the methods section, enrollment was optional. The project protocol has been approved by the ethical committee of Tehran University of Medical Sciences (IR.TUMS.NI.REC.1400.016).

Funding

This study was funded by Tehran University of Medical Sciences (grant number: 1400-1-233-52949).

References

  • 1.Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816–21. doi: 10.1177/1352458520970841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rodriguez Llorian E, Zhang W, Khakban A, Patten S, Traboulsee A, Oh J, et al. Productivity loss among people with early multiple sclerosis: a Canadian study. Mult Scler. 2022;28(9):1414–23. doi: 10.1177/13524585211069070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Maltby VE, Lea RA, Reeves P, Saugbjerg B, Lechner-Scott J. Reduced cognitive function contributes to economic burden of multiple sclerosis. Mult Scler Relat Disord. 2022;60:103707. doi: 10.1016/j.msard.2022.103707. [DOI] [PubMed] [Google Scholar]
  • 4. Wang J, Jelcic I, Mühlenbruch L, Haunerdinger V, Toussaint NC, Zhao Y, et al. HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis. Cell 2020;183(5):1264-81.e20. 10.1016/j.cell.2020.09.054. [DOI] [PMC free article] [PubMed]
  • 5.Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25–36. doi: 10.1038/nrneurol.2016.187. [DOI] [PubMed] [Google Scholar]
  • 6.Keane JT, Afrasiabi A, Schibeci SD, Fewings N, Parnell GP, Swaminathan S, et al. Gender and the sex hormone estradiol affect multiple sclerosis risk gene expression in Epstein-Barr virus-infected B cells. Front Immunol. 2021;12:732694. doi: 10.3389/fimmu.2021.732694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lundström W, Gustafsson R. Human herpesvirus 6A is a risk factor for multiple sclerosis. Front Immunol. 2022;13:840753. doi: 10.3389/fimmu.2022.840753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kalincik T, Tremlett H, Ascherio A. High BMI in youths as a modifiable risk factor for multiple sclerosis: weighing up the evidence. Neurology. 2021;97(23):1057–8. doi: 10.1212/wnl.0000000000012966. [DOI] [PubMed] [Google Scholar]
  • 9.Scazzone C, Agnello L, Bivona G, Lo Sasso B, Ciaccio M. Vitamin D and genetic susceptibility to multiple sclerosis. Biochem Genet. 2021;59(1):1–30. doi: 10.1007/s10528-020-10010-1. [DOI] [PubMed] [Google Scholar]
  • 10.Maroufi H, Mortazavi SH, Sahraian MA, Eskandarieh S. Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: a systematic review. Curr J Neurol. 2021;20(3):166–84. doi: 10.18502/cjn.v20i3.7693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Farah MJ. The neuroscience of socioeconomic status: correlates, causes, and consequences. Neuron. 2017;96(1):56–71. doi: 10.1016/j.neuron.2017.08.034. [DOI] [PubMed] [Google Scholar]
  • 12.Pakdel M, Karin Hedström A, Bidkhori M, Hadei M, Kazemi Moghaddam V, Sarmadi M, et al. Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran? Acta Neurol Scand. 2019;140(5):328–35. doi: 10.1111/ane.13148. [DOI] [PubMed] [Google Scholar]
  • 13.Harding KE, Wardle M, Carruthers R, Robertson N, Zhu F, Kingwell E, et al. Socioeconomic status and disability progression in multiple sclerosis: a multinational study. Neurology. 2019;92(13):e1497–e506. doi: 10.1212/wnl.0000000000007190. [DOI] [PubMed] [Google Scholar]
  • 14.Vasileiou ES, Filippatou AG, Pimentel Maldonado D, Kalaitzidis G, Ehrhardt H, Lambe J, et al. Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis. Brain. 2021;144(12):3664–73. doi: 10.1093/brain/awab342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gómez-Figueroa E, de Saráchaga AJ, García-Estrada C, Casallas-Vanegas A, Delgado-García G, Garcia-Martinez P, et al. Socioeconomic status and access to multiple sclerosis treatment in Mexico. Mult Scler Relat Disord. 2021;52:102967. doi: 10.1016/j.msard.2021.102967. [DOI] [PubMed] [Google Scholar]
  • 16.Goulden R, Ibrahim T, Wolfson C. Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review. Eur J Neurol. 2015;22(6):899–911. doi: 10.1111/ene.12586. [DOI] [PubMed] [Google Scholar]
  • 17.Hillert J. Socioeconomic status and multiple sclerosis outcome. Nat Rev Neurol. 2020;16(4):191–2. doi: 10.1038/s41582-020-0329-3. [DOI] [PubMed] [Google Scholar]
  • 18.Mohtasham Alsharie A, Rafiee F, Rezaeimanesh N, Naser Moghadasi A, Sahraian MA, Eskandarieh S. Stressful life events and the risk of primary progressive multiple sclerosis: a population-based case-control study. Mult Scler Relat Disord. 2021;51:102937. doi: 10.1016/j.msard.2021.102937. [DOI] [PubMed] [Google Scholar]
  • 19. The World Bank. Islamic Republic of Iran. Available from: https://data.worldbank.org/country/IR. Accessed April 3, 2022.
  • 20.Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018. BMC Neurol. 2020;20(1):169. doi: 10.1186/s12883-020-01747-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Azami M, YektaKooshali MH, Shohani M, Khorshidi A, Mahmudi L. Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis. PLoS One. 2019;14(4):e0214738. doi: 10.1371/journal.pone.0214738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Asadollahi M, Darvishi A, Azimi A, Annabi M, Jafariazar Z, Heshmat R. Estimation the medical cost of multiple sclerosis in Iran; 2019-2020. BMC Health Serv Res. 2022;22(1):137. doi: 10.1186/s12913-022-07551-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Amirsadri M, Rahimi F, Khajepour A. Cost of illness of multiple sclerosis in Isfahan, Iran, from a social perspective: a comparison of the human-capital and friction-cost methods. Value Health Reg Issues. 2022;30:26–30. doi: 10.1016/j.vhri.2021.10.006. [DOI] [PubMed] [Google Scholar]
  • 24.Sahraian MA, Naser Moghadasi A, Eskandarieh S. Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis. Curr J Neurol. 2021;20(1):15–22. doi: 10.18502/cjn.v20i1.6375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Shahin S, Eskandarieh S, Naser Moghadasi A, Razazian N, Baghbanian SM, Ashtari F, et al. Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set. Mult Scler Relat Disord. 2019;33:158–61. doi: 10.1016/j.msard.2019.06.009. [DOI] [PubMed] [Google Scholar]
  • 26.Ghane Ezabadi S, Sahraian MA, Maroufi H, Shahrbaf MA, Eskandarieh S. Global assessment of characteristics of multiple sclerosis registries; a systematic review. Mult Scler Relat Disord. 2022;63:103928. doi: 10.1016/j.msard.2022.103928. [DOI] [PubMed] [Google Scholar]
  • 27. National Multiple Sclerosis Registry of Iran. Available from: https://nmsri.ir/?page_id=228. Accessed November 22, 2022.
  • 28.Carroll WM. 2017 McDonald MS diagnostic criteria: evidence-based revisions. Mult Scler. 2018;24(2):92–5. doi: 10.1177/1352458517751861. [DOI] [PubMed] [Google Scholar]
  • 29. Zarabi A, Shahivandi A. An Analysis of distribution of economic development indices in Iran provinces. Geography and Environmental Planning 2010;21(2):17-32. [Persian].
  • 30.Azadi A, Delangizan S, Falahati A. The role of governments in Iran regional development (case study: tenth government) Iran Econ Rev. 2021;25(1):1–20. doi: 10.22059/ier.2021.81856. [DOI] [Google Scholar]
  • 31. Statistical Centre of Iran. A Selection of Labour Force Survey Results. Available from: https://amar.org.ir/Portals/1/releases/lfs/LFS-Spring-1399.pdf?ver=X50nL6Dobqu4uIAfc40YUA%3d%3d. Accessed April 6, 2022.
  • 32.Ghadiri F, Sahraian MA, Baghbanian SM, Ashtari F, Razazian N, Majdinasab N, et al. Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. Mult Scler Relat Disord. 2022;61:103777. doi: 10.1016/j.msard.2022.103777. [DOI] [PubMed] [Google Scholar]
  • 33.Rzepiński Ł, Zawadka-Kunikowska M, Kucharczuk J, Newton J, Zalewski P. New insights into the socio-economic aspects of multiple sclerosis in a cohort of Polish patients. Ann Agric Environ Med. 2021;28(1):99–106. doi: 10.26444/aaem/117962. [DOI] [PubMed] [Google Scholar]
  • 34.Blinkenberg M, Kjellberg J, Ibsen R, Magyari M. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: a Danish nationwide population-based study. Mult Scler Relat Disord. 2020;46:102567. doi: 10.1016/j.msard.2020.102567. [DOI] [PubMed] [Google Scholar]
  • 35.Razazian N, Eskandarieh S, Siabani S, Afshari D, Sahraian MA, Khezri O, et al. Prevalence of multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020) Mult Scler Relat Disord. 2022;57:103441. doi: 10.1016/j.msard.2021.103441. [DOI] [PubMed] [Google Scholar]
  • 36.Hashemilar M, Savadi Ouskui D, Farhoudi M, Ayromlou H, Asadollahi A. Multiple sclerosis in East-Azerbaijan, north west Iran. Neurol Asia. 2011;16(2):127–31. [Google Scholar]
  • 37.Wandall-Holm MF, Andersen MA, Buron MD, Magyari M. Aging with multiple sclerosis: age-related factors and socioeconomic risks. Front Neurol. 2022;13:818652. doi: 10.3389/fneur.2022.818652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Henríquez K, Molt F, Gajardo J, Cortés B, Ramirez-Santana M. Sociodemographic and clinical characteristics of people with multiple sclerosis and neuro-myelitis optica spectrum disorder in a central northern region of Chile: a prevalence study. Mult Scler Relat Disord. 2022;61:103750. doi: 10.1016/j.msard.2022.103750. [DOI] [PubMed] [Google Scholar]
  • 39.Engelhard J, Oleske DM, Schmitting S, Wells KE, Talapala S, Barbato LM. Multiple sclerosis by phenotype in Germany. Mult Scler Relat Disord. 2022;57:103326. doi: 10.1016/j.msard.2021.103326. [DOI] [PubMed] [Google Scholar]
  • 40.Luetic GG, Menichini ML, Vrech C, Pappolla A, Patrucco L, Cristiano E, et al. Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis? Mult Scler Relat Disord. 2022;58:103401. doi: 10.1016/j.msard.2021.103401. [DOI] [PubMed] [Google Scholar]
  • 41.von Wyl V, Décard BF, Benkert P, Lorscheider J, Hänni P, Lienert C, et al. Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment. Eur J Neurol. 2020;27(6):1066–75. doi: 10.1111/ene.14191. [DOI] [PubMed] [Google Scholar]
  • 42.Scalfari A, Neuhaus A, Daumer M, Deluca GC, Muraro PA, Ebers GC. Early relapses, onset of progression, and late outcome in multiple sclerosis. JAMA Neurol. 2013;70(2):214–22. doi: 10.1001/jamaneurol.2013.599. [DOI] [PubMed] [Google Scholar]
  • 43.Ramachandran S, Strange RC, Jones PW, Kalra S, Nayak D, Hawkins CP. Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model. Mult Scler Relat Disord. 2014;3(5):593–9. doi: 10.1016/j.msard.2014.06.002. [DOI] [PubMed] [Google Scholar]
  • 44.Salehi Z, Almasi-Hashiani A, Sahraian MA, Ashtari F, Baghbanian SM, Razazian N, et al. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study. BMC Neurol. 2022;22(1):76. doi: 10.1186/s12883-022-02609-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ehtesham N, Zare Rafie M, Mosallaei M. The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis. BMC Neurol. 2021;21(1):246. doi: 10.1186/s12883-021-02267-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Simmons SB, Schippling S, Giovannoni G, Ontaneda D. Predicting disability worsening in relapsing and progressive multiple sclerosis. Curr Opin Neurol. 2021;34(3):312–21. doi: 10.1097/wco.0000000000000928. [DOI] [PubMed] [Google Scholar]
  • 47.Calocer F, Dejardin O, Kwiatkowski A, Bourre B, Vermersch P, Hautecoeur P, et al. Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients. Mult Scler Relat Disord. 2020;40:101930. doi: 10.1016/j.msard.2020.101930. [DOI] [PubMed] [Google Scholar]
  • 48.Lehmann AI, Rodgers S, Calabrese P, Kamm CP, von Wyl V, Bauer GF. Relationship between Job Demands-Resources and turnover intention in chronic disease - the example of multiple sclerosis. Stress Health. 2021;37(5):940–8. doi: 10.1002/smi.3054. [DOI] [PubMed] [Google Scholar]
  • 49.Ware ME, McCully KK. Impact of marriage on physical activity behavior in women with multiple sclerosis. Disabil Rehabil. 2022;44(20):5941–9. doi: 10.1080/09638288.2021.1953622. [DOI] [PubMed] [Google Scholar]
  • 50.Tavazzi E, Cazzoli M, Pirastru A, Blasi V, Rovaris M, Bergsland N, et al. Neuroplasticity and motor rehabilitation in multiple sclerosis: a systematic review on MRI markers of functional and structural changes. Front Neurosci. 2021;15:707675. doi: 10.3389/fnins.2021.707675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Sanai SA, Saini V, Benedict RH, Zivadinov R, Teter BE, Ramanathan M, et al. Aging and multiple sclerosis. Mult Scler. 2016;22(6):717–25. doi: 10.1177/1352458516634871. [DOI] [PubMed] [Google Scholar]
  • 52.Shabany M, Ayoubi S, Naser Moghadasi A, Najafi M, Eskandarieh S. Explaining the individual challenges of women affected by neuromyelitis optica and multiple sclerosis: a comparative content analysis Study. Clin Neurol Neurosurg. 2021;207:106789. doi: 10.1016/j.clineuro.2021.106789. [DOI] [PubMed] [Google Scholar]
  • 53.Zarghami A, Nourmohammadi ST, Hojjati SMM. Urbanization theory and socioeconomic changeover of multiple sclerosis in Iran. Acta Neurol Scand. 2020;141(3):256. doi: 10.1111/ane.13159. [DOI] [PubMed] [Google Scholar]
  • 54.Pourfaraj A, Mehregan N, Karimi Potanlar S, Eskandariata MR. Regional inequality in Iran and the impact of economic factors: a spatial econometric approach. Iran Econ Rev. 2019;23(2):297–318. [Google Scholar]

Articles from Archives of Iranian Medicine are provided here courtesy of Academy of Medical Sciences of the I.R. of Iran

RESOURCES